Spotlight
Video

CDK 4/6 Inhibitor Improves PFS for Patients with HR+/HER- Breast Cancer

Loading........
Description: Hope S. Rugo, MD of the UCSF Medical Center discusses the state of CDK 4/6 Inhibitors for Patients with HR+/HER- Breast Cancer
Shared By : GiantsOfCancerCare
Posted on : 06/18/15
Added : 4 years ago
Category : Breast Cancer